Literature DB >> 20360002

Axonal neuregulin 1 type III activates NF-kappaB in Schwann cells during myelin formation.

Allison S Limpert1, Bruce D Carter.   

Abstract

The formation of myelin requires a series of complex signaling events initiated by the axon to surrounding glial cells, which ultimately respond by tightly wrapping the axon with layers of specialized plasma membrane thereby allowing for saltatory conduction. Activation of the transcription factor NF-kappaB in Schwann cells has been suggested to be critical for these cells to differentiate into a myelinating phenotype; however, the mechanisms by which it is activated have yet to be elucidated. Here, we demonstrate that axonal membranes are sufficient to promote NF-kappaB activation in cultured Schwann cells and identify neuregulin 1 (NRG1), specifically the membrane-bound type III isoform, as the signal responsible for activating this transcription factor. Surprisingly, neither membrane-bound type I nor the soluble NRG1 EGF domain could activate NF-kappaB, indicating that type III induces a qualitatively unique signal. The transcriptional activity of NF-kappaB was significantly enhanced by treatment with forskolin, indicating these two signals converge for maximal activation. Both ErbB2 and -3 receptors were required for transducing the NRG1 signal, because gene deletion of ErbB3 in Schwann cells or treatment with the ErbB2 selective inhibitor, PKI-166, prevented the stimulation of NF-kappaB by axonal membranes. Finally, PKI-166 blocked the activation of the transcription factor in myelinating neuron/Schwann cell co-cultures and in vivo, in developing sciatic nerves. Taken together, these data establish NRG1 type III as the activator of NF-kappaB during myelin formation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360002      PMCID: PMC2878070          DOI: 10.1074/jbc.M109.098780

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Growth factor-specific signaling pathway stimulation and gene expression mediated by ErbB receptors.

Authors:  C Sweeney; D Fambrough; C Huard; A J Diamonti; E S Lander; L C Cantley; K L Carraway
Journal:  J Biol Chem       Date:  2001-04-10       Impact factor: 5.157

2.  Ligand discrimination in signaling through an ErbB4 receptor homodimer.

Authors:  C Sweeney; C Lai; D J Riese; A J Diamonti; L C Cantley; K L Carraway
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

Review 3.  Neuregulin, a factor with many functions in the life of a schwann cell.

Authors:  A N Garratt; S Britsch; C Birchmeier
Journal:  Bioessays       Date:  2000-11       Impact factor: 4.345

4.  The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain.

Authors:  J Y Wang; S J Miller; D L Falls
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

5.  Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.

Authors:  S Pianetti; M Arsura; R Romieu-Mourez; R J Coffey; G E Sonenshein
Journal:  Oncogene       Date:  2001-03-15       Impact factor: 9.867

Review 6.  HER-targeted tyrosine-kinase inhibitors.

Authors:  José Baselga; Lisa A Hammond
Journal:  Oncology       Date:  2002       Impact factor: 2.935

7.  A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells.

Authors:  Punita Dhawan; Ann Richmond
Journal:  J Biol Chem       Date:  2001-12-28       Impact factor: 5.157

Review 8.  Tyrosine kinase inhibitors: from rational design to clinical trials.

Authors:  P Traxler; G Bold; E Buchdunger; G Caravatti; P Furet; P Manley; T O'Reilly; J Wood; J Zimmermann
Journal:  Med Res Rev       Date:  2001-11       Impact factor: 12.944

9.  Membrane-bound neuregulin1 type III actively promotes Schwann cell differentiation of multipotent Progenitor cells.

Authors:  Rainer Leimeroth; Christian Lobsiger; Agnes Lüssi; Verdon Taylor; Ueli Suter; Lukas Sommer
Journal:  Dev Biol       Date:  2002-06-15       Impact factor: 3.582

10.  c-jun is essential for sympathetic neuronal death induced by NGF withdrawal but not by p75 activation.

Authors:  M Palmada; S Kanwal; N J Rutkoski; C Gustafson-Brown; R S Johnson; R Wisdom; B D Carter; C Gufstafson-Brown
Journal:  J Cell Biol       Date:  2002-08-05       Impact factor: 10.539

View more
  20 in total

1.  Nuclear factor-κB activation in Schwann cells regulates regeneration and remyelination.

Authors:  Paul D Morton; Joshua T Johnstone; Angel Y Ramos; Daniel J Liebl; Mary Bartlett Bunge; John R Bethea
Journal:  Glia       Date:  2012-01-24       Impact factor: 7.452

2.  Activation of NF-κB in Schwann cells is dispensable for myelination in vivo.

Authors:  Paul D Morton; Anna Dellarole; Michelle H Theus; Winston M Walters; Summer S Berge; John R Bethea
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

Review 3.  Pluripotent stem cells for Schwann cell engineering.

Authors:  Ming-San Ma; Erik Boddeke; Sjef Copray
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 4.  Negative regulators of schwann cell differentiation-novel targets for peripheral nerve therapies?

Authors:  André Heinen; Helmar C Lehmann; Patrick Küry
Journal:  J Clin Immunol       Date:  2012-09-06       Impact factor: 8.317

Review 5.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

6.  The role of neuregulin-1 in the response to nerve injury.

Authors:  Florence R Fricker; David Lh Bennett
Journal:  Future Neurol       Date:  2011-11

7.  Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.

Authors:  Agnes Patzkó; Yunhong Bai; Mario A Saporta; István Katona; Xingyao Wu; Domenica Vizzuso; M Laura Feltri; Suola Wang; Lisa M Dillon; John Kamholz; Daniel Kirschner; Fazlul H Sarkar; Lawrence Wrabetz; Michael E Shy
Journal:  Brain       Date:  2012-12       Impact factor: 13.501

8.  Mapping haplotype-haplotype interactions with adaptive LASSO.

Authors:  Ming Li; Roberto Romero; Wenjiang J Fu; Yuehua Cui
Journal:  BMC Genet       Date:  2010-08-27       Impact factor: 2.797

9.  NF-κB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation.

Authors:  Allison S Limpert; Shujun Bai; Malathi Narayan; Jiang Wu; Sung Ok Yoon; Bruce D Carter; Q Richard Lu
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

10.  p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB.

Authors:  Iram Ahmad; Wei Ying Yue; Augusta Fernando; J Jason Clark; Erika A Woodson; Marlan R Hansen
Journal:  Glia       Date:  2014-06-26       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.